Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68198, USA; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Semin Cancer Biol. 2022 Nov;86(Pt 3):457-472. doi: 10.1016/j.semcancer.2022.02.003. Epub 2022 Feb 3.
Chemokines are well equipped with chemo-attractive signals that can regulate cancer cell trafficking to specific organ sites. Currently, updated concepts have revealed the diverse role of chemokines in the biology of cancer initiation and progression. Genomic instabilities and alterations drive tumor heterogeneity, providing more options for the selection and metastatic progression to cancer cells. Tumor heterogeneity and acquired drug resistance are the main obstacles in managing cancer therapy and the primary root cause of metastasis. Studies emphasize that multiple chemokine/receptor axis are involved in cancer cell-mediated organ-specific distant metastasis. One of the persuasive mechanisms for heterogeneity and subsequent events is sturdily interlinked with the crosstalk between chemokines and their receptors on cancer cells and tissue-specific microenvironment. Among different metastatic niches, skeletal metastasis is frequently observed in the late stages of prostate, breast, and lung cancer and significantly reduces the survival of cancer patients. Therefore, it is crucial to elucidate the role of chemokines and their receptors in metastasis and bone remodeling. Here, we review the potential chemokine/receptor axis in tumorigenesis, tumor heterogeneity, metastasis, and vicious cycle in bone microenvironment.
趋化因子具有良好的化学吸引信号,可以调节癌细胞向特定器官部位的迁移。目前,更新的概念揭示了趋化因子在癌症发生和发展生物学中的多种作用。基因组不稳定性和改变驱动肿瘤异质性,为癌细胞的选择和转移进展提供了更多的选择。肿瘤异质性和获得性耐药性是癌症治疗管理的主要障碍,也是转移的主要根源。研究强调,多种趋化因子/受体轴参与了癌细胞介导的器官特异性远处转移。异质性和随后事件的一个有说服力的机制与趋化因子与其在癌细胞和组织特异性微环境上的受体之间的串扰密切相关。在不同的转移龛中,骨骼转移在前列腺癌、乳腺癌和肺癌的晚期经常发生,并显著降低了癌症患者的生存率。因此,阐明趋化因子及其受体在转移和骨重塑中的作用至关重要。在这里,我们综述了趋化因子/受体轴在肿瘤发生、肿瘤异质性、转移和骨微环境中的恶性循环中的潜在作用。